The Washington Post reports the FDA issued a warning for consumers against “young blood” plasma infusions purported to treat Parkinson’s, multiple sclerosis, PTSD, Alzheimer’s, and other conditions. In a statement, FDA Commissioner Scott Gottlieb and Peter Marks, director of the agency’s Center for Biologics Evaluation and Research said, “There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions, and there are risks associated with the use of any plasma product.”
USA Today quotes Gottlieb and Marks, who said, “Simply put, we’re concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies.”
Bloomberg News reports, “Gottlieb and Marks said none of the plasma treatments has gone through the rigorous testing required by the agency,” but a company providing plasma treatments donated by young people said “experiments in mice called parabiosis provided the inspiration to deliver treatments with young plasma.” According to the FDA, risks “[include] allergic reactions, circulatory overload, lung injury and infectious disease transmission.”
CNBC reports, “In addition to there being ‘no compelling clinical evidence on its efficacy,’ the FDA says there’s no information on the appropriate dosing.”
From the news release of the American Association for Justice.
